Chapter 5 Rhesus Cytomegalovirus. A Nonhuman Primate Model for The Study of Human Cytomegalovirus

Advances in Virus Research

Volumn 72, Issue , 2008, Pages 207-226

  Yue, Yujuan ^a   Barry, Peter A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; MACACA; MONKEY DISEASE; PATHOGENICITY; REVIEW; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; DISEASE MODELS, ANIMAL; MACACA MULATTA; MONKEY DISEASES;

EID: 57149105521     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)00405-3     Document Type: Review

References (96)

1. Adler S.P., Starr S.E., Plotkin S.A., Hempfling S.H., Buis J., Manning M.L., and Best A.M. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 171 (1995) 26-32
2. Alford C.A., and Britt W.J. Cytomegalovirus. In: Roizman B., Whitley R.J., and Lopez C. (Eds). The Human Herpesviruses (1993), Raven Press, New York 227-255
3. Andrade M.R., Yee J., Barry P., Spinner A., Roberts J.A., Cabello P.H., Leite J.P., and Lerche N.W. Prevalence of antibodies to selected viruses in a long-term closed breeding colony of rhesus macaques (Macaca mulatta) in Brazil. Am. J. Primatol. 59 3 (2003) 123-128
4. Arav-Boger R., Foster C.B., Zong J.C., and Pass R.F. Human cytomegalovirus-encoded alpha-chemokines exhibit high sequence variability in congenitally infected newborns. J. Infect. Dis. 193 6 (2006) 788-791
5. Asher D.M., Gibbs Jr. C.J., Lang D.J., Gadjusek D.C., and Chanock R.M. Persistent shedding of cytomegalovirus in the urine of healthy rhesus monkeys. Proc. Soc. Exp. Biol. Med. 145 (1974) 794-801
6. Aucouturier J., Dupuis L., Deville S., Ascarateil S., and Ganne V. Montanide ISA 720 and 51: A new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev. Vaccines 1 1 (2002) 111-118
7. Baroncelli S., Barry P.A., Capitanio J.P., Lerche N.W., Otsyula M., and Mendoza S.P. Cytomegalovirus and simian immunodeficiency virus coinfection: Longitudinal study of antibody responses and disease progression. J. Acquir. Immune Defic. Syndr. 15 (1997) 5-15
8. Barry P.A., and Chang W.-L.W. Primate betaherpesviruses. In: Arvin A., Campadielli G., Moore P., Mocarski E., Roizman B., Whitley R., and Yamanishi K. (Eds). Human Herpesviruses: Biology, Therapy and Immunoprophylaxis (2007), Cambridge University Press, Cambridge 1051-1075
9. Barry P.A., and Strelow L. Development of breeding populations of rhesus macaques that are specific pathogen free for rhesus cytomegalovirus. Comp. Med. 58 (2008) 43-46
10. Barry P.A., Alcendor D.J., Power M.D., Kerr H., and Luciw P.A. Nucleotide sequence and molecular analysis of the rhesus cytomegalovirus immediate-early gene and the UL121-117 open reading frames. Virology 215 (1996) 61-72
11. Barry P.A., Lockridge K.M., Salamat S., Tinling S.P., Yue Y., Zhou S.S., Gospe Jr. S.M., Britt W.J., and Tarantal A.F. Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J. 47 1 (2006) 49-64
12. Baskin G.B. Disseminated cytomegalovirus infection in immunodeficient rhesus macaques. Am. J. Pathol. 129 (1987) 345-352
13. Bontrop R.E., Otting N., Slierendregt B.L., and Lanchbury J.S. Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol. Rev. 143 (1995) 33-62
14. Boppana S.B., Fowler K.B., Britt W.J., Stagno S., and Pass R.F. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104 (1999) 55-60
15. Cha T., Tom E., Kemble G., Duke G., Mocarski E., and Spaete R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70 1 (1996) 78-83
16. Chan K.S., and Kaur A. Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques. J. Immunol. Methods 325 1-2 (2007) 20-34
17. Chang W.L., and Barry P.A. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 77 9 (2003) 5073-5083
18. Chang W.L., Tarantal A.F., Zhou S.S., Borowsky A.D., and Barry P.A. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J. Virol. 76 18 (2002) 9493-9504
19. Chang W.L., Baumgarth N., Yu D., and Barry P.A. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78 16 (2004) 8720-8731
20. Chang W.L., Baumgarth N., Eberhardt M.K., Lee C.Y., Baron C.A., Gregg J.P., and Barry P.A. Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. J. Immunol. 178 12 (2007) 7794-7804
21. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchison C.A., Kouzarides T., Martignetti J.A., Preddie E., Satchwell S.C., et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154 (1990) 125-169
22. Chou S. Antiviral drug resistance in human cytomegalovirus. Transpl. Infect. Dis. 1 2 (1999) 105-114
23. Conway M.D., Didier P., Fairburn B., Soike K.F., Martin L., Murphy-Corb M., Meiners N., and Insler M.S. Ocular manifestation of simian immunodeficiency syndrome (SAIDS). Curr. Eye Res. 9 (1990) 759-770
24. Covell W. Occurrence of intranuclear inclusions of monkeys unaccompanied by specific signs of disease. Am. J. Pathol. 8 (1932) 151-158
25. Cowdry W., and Scott G. Nuclear inclusions in kidneys of Macacus rhesus monkeys. Am. J. Pathol. 11 (1935) 659-668
26. Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J., McGeoch D.J., and Hayward G.S. The human cytomegalovirus genome revisited: Comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84 Pt. 1 (2003) 17-28
27. Dollard S.C., Grosse S.D., and Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17 5 (2007) 355-363
28. Drexler I., Staib C., and Sutter G. Modified vaccinia virus Ankara as antigen delivery system: How can we best use its potential?. Curr. Opin. Biotechnol. 15 6 (2004) 506-512
29. Elek S.D., and Stern H. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1 7845 (1974) 1-5
30. Engel G.A., Pizzaro M., Cortes J., Shaw E., Fuentes A., Lerche N., Barry P.A., Cohn D., and Jones-Engel L. Seroprevalence of antibodies to enzootic simian viruses among the Gibraltar macaques (M. sylvanus). Emerg. Infect. Dis. 64 (2008) 1112-1115
31. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., and Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326 (1992) 663-667
32. Gonczol E., and Plotkin S. Development of a cytomegalovirus vaccine: Lessons from recent clinical trials. Expert. Opin. Biol. Ther. 1 3 (2001) 401-412
33. Haigwood N.L. Predictive value of primate models for AIDS. AIDS Rev. 6 4 (2004) 187-198
34. Hansen S.G., Strelow L.I., Franchi D.C., Anders D.G., and Wong S.W. Complete sequence and genomic analysis of rhesus cytomegalovirus. J. Virol. 77 (2003) 6620-6636
35. Hassan-Walker A.F., Okwuadi S., Lee L., Griffiths P.D., and Emery V.C. Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus. J. Med. Virol. 74 4 (2004) 573-579
36. Hindle E., and Stevenson A.C. Hitherto undescribed intranuclear bodies in the wild rat and monkeys, compared with known virus bodies in other animals. Trans. R. Soc. Trop. Med. Hyg. 23 (1929-1930) 327
37. Huff J.L., Eberle R., Capitanio J., Zhou S.S., and Barry P.A. Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques. J. Gen. Virol. 84 (2003) 83-92
38. Jones B.C., Logsdon N.J., Josephson K., Cook J., Barry P.A., and Walter M.R. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl. Acad. Sci. USA 99 14 (2002) 9404-9409
39. Jones-Engel L., Engel G.A., Heidrich J., Chalise M., Poudel N., Viscidi R., Barry P.A., Allan J.S., Grant R., and Kyes R. Temple monkeys and health implications of commensalism, Kathmandu, Nepal. Emerg. Infect. Dis. 12 6 (2006) 900-906
40. Karlin S., Mocarski E.S., and Schachtel G.A. Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J. Virol. 68 3 (1994) 1886-1902
41. Kaur A., Daniel M.D., Hempel D., Lee-Parritz D., Hirsch M.S., and Johnson R.P. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected macaques. J. Virol. 70 (1996) 7725-7733
42. Kaur A., Hale C.L., Noren B., Kassis N., Simon M.A., and Johnson R.P. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: Inverse relationship with CMV viremia. J. Virol. 76 8 (2002) 3646-3658
43. Kaur A., Kassis N., Hale C.L., Simon M., Elliott M., Gomez-Yafal A., Lifson J.D., Desrosiers R.C., Wang F., Barry P., Mach M., and Johnson R.P. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J. Virol. 77 10 (2003) 5749-5758
44. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., and Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. 97 4 (2000) 1695-1700
45. Krosky P.M., Underwood M.R., Turk S.R., Feng K.W., Jain R.K., Ptak R.G., Westerman A.C., Biron K.K., Townsend L.B., and Drach J.C. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72 6 (1998) 4721-4728
46. Kuhn E.M., Stolte N., Matz-Rensing K., Mach M., Stahl-Henning C., Hunsmann G., and Kaup F.J. Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet. Pathol. 36 1 (1999) 51-56
47. Landolfo S., Gariglio M., Gribaudo G., and Lembo D. The human cytomegalovirus. Pharmacol. Ther. 98 3 (2003) 269-297
48. Lockridge K.M., Sequar G., Zhou S.S., Yue Y., Mandell C.M., and Barry P.A. Pathogenesis of experimental rhesus cytomegalovirus infection. J. Virol. 73 (1999) 9576-9583
49. Lockridge K.M., Zhou S.S., Kravitz R.H., Johnson J.L., Sawai E.T., Blewett E.L., and Barry P.A. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268 2 (2000) 272-280
50. London W.T., Martinez A.J., Houff S.A., Wallen W.C., Curfman B.L., Traub R.G., and Sever J.L. Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 33 (1986) 323-331
51. Lurain N.S., Fox A.M., Lichy H.M., Bhorade S.M., Ware C.F., Huang D.D., Kwan S.P., Garrity E.R., and Chou S. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol. J. 3 (2006) 4
52. McCormick A.L., Skaletskaya A., Barry P.A., Mocarski E.S., and Goldmacher V.S. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316 (2003) 221-233
53. McGeoch D.J., Cook S., Dolan A., Jamieson F.E., and Telford E.A. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247 3 (1995) 443-458
54. McGeoch D.J., Rixon F.J., and Davison A.J. Topics in herpesvirus genomics and evolution. Virus Res. 117 1 (2006) 90-104
55. Medicine I.O. Vaccines for the 21st Century (2000), National Academy Press, Washington, DC 6
56. Mocarski Jr. E.S. Immunomodulation by cytomegaloviruses: Manipulative strategies beyond evasion. Trends Microbiol. 10 7 (2002) 332-339
57. Morello C.S., Ye M., and Spector D.H. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. J. Virol. 76 10 (2002) 4822-4835
58. Murphy E., Rigoutsos I., Shibuya T., and Shenk T.E. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. USA 100 (2003) 14976-14981
59. Murphy E., Yu D., Grimwood J., Schmutz J., Dickson M., Jarvis M.A., Hahn G., Nelson J.A., Myers R.M., and Shenk T.E. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100 (2003) 14976-14981
60. Neff B.J., Weibel R.E., Buynak E.B., McLean A.A., and Hilleman M.R. Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169. Proc. Soc. Exp. Biol. Med. 160 1 (1979) 32-37
61. North T.W., Sequar G., Townsend L.B., Drach J.C., and Barry P.A. Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidizole nucleosides. Antimicrob. Agents Chemother 48 (2004) 2760-2765
62. Novak Z., Ross S.A., Patro R.K., Pati S.K., Kumbla R.A., Brice S., and Boppana S.B. Cytomegalovirus strain diversity in seropositive women. J. Clin. Microbiol. 46 3 (2008) 882-886
63. Oxford K.L., Eberhardt M.K., Yang K.W., Strelow L., Kelly S., Zhou S.S., and Barry P.A. Protein coding content of the U(L)b′ region of wild-type rhesus cytomegalovirus. Virology 373 1 (2008) 181-188
64. Pande N.T., Powers C., Ahn K., and Fruh K. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J. Virol. 79 9 (2005) 5786-5798
65. Pass R.F. Cytomegalovirus. In: Knipe D., and Howley P. (Eds). Fields Virology (2001), Lippincott, Williams and Wilkins, Philadelphia 2675-2705
66. Pearson T.C., Trambley J., Odom K., Anderson D.C., Cowan S., Bray R., Lin A., Hollenbaugh D., Aruffo A., Siadak A.W., Strobert E., Hennigar R., et al. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 74 7 (2002) 933-940
67. Pignatelli S., Dal Monte P., Rossini G., and Landini M.P. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol. 14 6 (2004) 383-410
68. Plotkin S.A. Cytomegalovirus vaccine. Am. Heart J. 138 5 Pt. 2 (1999) S484-S487
69. Plotkin S.A. Vaccination against cytomegalovirus. Arch. Virol. Suppl. 17 (2001) 121-134
70. Powers C., and Früh K. Rhesus CMV: An emerging animal model for human CMV. Med. Microbiol. Immunol. 197 (2008) 109-115
71. Prichard M.N., Penfold M.E., Duke G.M., Spaete R.R., and Kemble G.W. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11 3 (2001) 191-200
72. Rivailler P., Kaur A., Johnson R.P., and Wang F. Genomic sequence of rhesus cytomegalovirus 180.92: Insights into the coding potential of rhesus cytomegalovirus. J. Virol. 80 8 (2006) 4179-4182
73. Sequar G., Britt W.J., Lakeman F.D., Lockridge K.M., Tarara R.P., Canfield D.R., Zhou S.S., Gardner M.B., and Barry P.A. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis. J. Virol. 76 15 (2002) 7661-7671
74. Shanley J.D., Morningstar J., and Jordan M.C. Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob. Agents Chemother. 28 2 (1985) 172-175
75. Spencer J.V., Lockridge K.M., Barry P.A., Lin G., Tsang M., Penfold M.E., and Schall T.J. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76 3 (2002) 1285-1292
76. Staczek J. Animal cytomegaloviruses. Microbiol. Rev. 54 3 (1990) 247-265
77. Stagno S. Cytomegalovirus. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infant. 3rd Ed. (1990), W. B. Saunders, Philadelphia 241-281
78. Stagno S., Pass R.F., Cloud G., Britt W.J., Henderson R.E., Walton P.D., Veren D.A., Page F., and Alford C.A. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus, and clinical outcome. J. Am. Med. Assoc. 256 (1986) 1904-1908
79. Stewart F.W., and Rhoads C.P. Lesions in nasal mucous membranes of monkeys with acute poliomyelitis. Proc. Soc. Exp. Biol. Med. 26 (1929) 664-665
80. Stratton K.R., Durch J.S., and Lawrence R.S. Vaccines for the 21st Century: A Tool for Decision making (2000), National Academy Press, Washington, DC
81. Swack N.S., and Hsiung G.D. Natural and experimental simian cytomegalovirus infections at a primate center. J. Med. Primatol. 11 (1982) 169-177
82. Swack N.S., Liu O.C., and Hsiung G.D. Cytomegalovirus infections of monkeys and baboons. Am. J. Epidemiol. 94 (1971) 397-402
83. Swanson R., Bergquam E., and Wong S.W. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility. Virology 240 2 (1998) 338-348
84. Tarantal A.F., Salamat S., Britt W.J., Luciw P.A., Hendrickx A.G., and Barry P.A. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J. Infect. Dis. 177 (1998) 446-450
85. Townsend L.B., Devivar R.V., Turk S.R., Nassiri M.R., and Drach J.C. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-d-ribofuranosyl)benzimidazoles. J. Med. Chem. 38 20 (1995) 4098-4105
86. Underwood M.R., Harvey R.J., Stanat S.C., Hemphill M.L., Miller T., Drach J.C., Townsend L.B., and Biron K.K. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72 1 (1998) 717-725
87. Villarreal E.C. Current and potential therapies for the treatment of herpes-virus infections. Prog. Drug Res. 60 (2003) 263-307
88. Vogel P., Weigler B.J., Kerr H., Hendrickx A., and Barry P.A. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44 (1994) 25-30
89. Wang Z., La Rosa C., Maas R., Ly H., Brewer J., Mekhoubad S., Daftarian P., Longmate J., Britt W.J., and Diamond D.J. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. J. Virol. 78 8 (2004) 3965-3976
90. Wang Z., La Rosa C., Lacey S.F., Maas R., Mekhoubad S., Britt W.J., and Diamond D.J. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. J. Clin. Virol. 35 3 (2006) 324-331
91. Wang Z., La Rosa C., Li Z., Ly H., Krishnan A., Martinez J., Britt W.J., and Diamond D.J. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1. Vaccine 25 6 (2007) 1132-1141
92. Yue Y., Zhou S.S., and Barry P.A. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. J. Gen. Virol. 84 Pt. 12 (2003) 3371-3379
93. Yue Y., Kaur A., Zhou S.S., and Barry P.A. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65). J. Gen. Virol. 87 Pt. 4 (2006) 777-787
94. Yue Y., Kaur A., Eberhardt M.K., Kassis N., Zhou S.S., Tarantal A.F., and Barry P.A. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques. J. Virol. 81 3 (2007) 1095-1109
95. Yue Y., Wang Z., Abel K., Li J., Strelow L., Mandarino A., Eberhardt M.K., Schmidt K.A., Diamond D.J., and Barry P.A. Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med. Microbiol. Immunol. 197 (2008) 117-123
96. Zhong J., and Khanna R. Vaccine strategies against human cytomegalovirus infection. Expert Rev. Anti Infect. Ther. 5 3 (2007) 449-459